However, only a nonsignificant trend was observed between LSM per 1-point increase and CKD stage ≥ 3 in both unadjusted and adjusted analyses 32 , 46 , 51 , 56 (unadjusted OR 1.412 [(95% CI 0.955, 2.089], p = 0.084; I 2 = 86.511, p = 0.001; Egger’s test = 0.120) and (adjusted OR 1.237 [95% CI 0.973, 1.573], p = 0.082; I 2 = 81.619, p = 0.004; Egger’s test = 0.084).
← all excerpts
Association of noninvasive tests of liver fibrosis with chronic kidney disease in MASLD: a systematic review and meta-analysis.
1
—
—